Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction-associated steatohepatitis?
Saved in:
| Title: | Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction-associated steatohepatitis? |
|---|---|
| Authors: | Polyzos SA; First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece., Kountouras J; Second Medical Clinic, School of Medicine, Ippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece., Duntas LH; Thyroid Section, Unit of Endocrinology, Diabetes and Metabolism, Evgenideion Hospital, National and Kapodistrian University of Athens, Athens, Greece., Targher G; Department of Medicine, University of Verona, Verona, Italy.; Metabolic Diseases Research Unit, IRCCS Sacro Cuore-Don Calabria Hospital, Negrar di Valpolicella (VR), Italy. |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2026 Apr; Vol. 28 (4), pp. 2507-2510. Date of Electronic Publication: 2026 Jan 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1463-1326 |
|---|---|
| DOI: | 10.1111/dom.70507 |
